Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy

  • تاریخ انتشار


  • حجم فایل (مگابایت)

    5.5 MB

  • ناشر

    Springer MB

  • زبان فایل

    english MB

قیمت این فایل :‌
  • 15,000تومان

With the increasing use of immune checkpoint inhibitors ICI across various cancers the trends for indication at earlier stages and the use of combination immunotherapy the frequency of ICI induced immune related adverse events irAE is expected to grow substantially Management of these irAE is challenging as it requires not only consideration of the toxicity but also risk benefit ratios with respect to the primary cancer Several rheumatic irAE have been reported with ICI therapy including arthritis myositis polymyalgia like syndromes sicca Sjogren like manifestations and several other less common systemic autoimmune features commonly associated with connective tissue disease

سایر کتب